Top compounds associated with response to EIF3C


Feature Type Standardized
Nominal ANOVA
mRNA semagacestat CTRPv2 pan-cancer AAC -0.04 0.3
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.058 0.3
mRNA necrostatin-1 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.038 0.3
mRNA JW-480 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA L-685458 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA purmorphamine CTRPv2 pan-cancer AAC 0.04 0.3
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.051 0.3
mRNA AZD1480 CTRPv2 pan-cancer AAC 0.057 0.3
Download CSV